A microRNA molecular modeling extension for prediction of colorectal cancer treatment

作者: Jian Li , Ulrich R. Mansmann

DOI: 10.1186/S12885-015-1437-0

关键词: Transcriptional regulationText miningMedicineBioinformaticsColorectal cancerSurgical oncologymicroRNAGeneIn silicoPersonalized medicine

摘要: Background: Several studies show that the regulatory impact of microRNAs (miRNAs) is an essential contribution to pathogenesis colorectal cancer (CRC). The expression levels diverse miRNAs are associated with specific clinical diagnoses and prognoses CRC. However, this association reveals very little actionable information regard how or whether treat a CRC patient. To address problem, we use miRNA data along other molecular predict individual response cell lines patients. Methods: A strategy has been developed join four types information: molecular, kinetic, genetic treatment for prediction Results: Information on regulation, including target regulation transcriptional miRNA, in integrated into silico model colon cancer. This applied study responses seven from NCI-60 ten agents targeting signaling pathways. Predictive results models without implemented compared advantages shown extended model. Finally, was 22 patients treatments sirolimus LY294002. can also replicate oncogenic tumor suppression roles therapeutic as reported literature. Conclusions: In summary, reveal detailed events be combined data, gene/miRNA enhance tumors. demonstrates regarding response.

参考文章(51)
Quyen Chu, Tannaz Armaghany, Glenn Mills, Jon D Wilson, Genetic alterations in colorectal cancer. Gastrointestinal cancer research : GCR. ,vol. 5, pp. 19- 27 ,(2012)
Alberto Gulino, Elisabetta Ferretti, Enrico De Smaele, Hedgehog signalling in colon cancer and stem cells Embo Molecular Medicine. ,vol. 1, pp. 300- 302 ,(2009) , 10.1002/EMMM.200900042
S. Tejpar, F. Bosman, M. Delorenzi, R. Fiocca, P. Yan, D. Klingbiel, D. Dietrich, E. Van Cutsem, R. Labianca, A. Roth, Microsatellite instability (MSI) in stage II and III colon cancer treated with 5FU-LV or 5FU-LV and irinotecan (PETACC 3-EORTC 40993-SAKK 60/00 trial) Journal of Clinical Oncology. ,vol. 27, pp. 4001- 4001 ,(2009) , 10.1200/JCO.2009.27.15_SUPPL.4001
Sonia A. Melo, Raghu Kalluri, Molecular Pathways: MicroRNAs as Cancer Therapeutics Clinical Cancer Research. ,vol. 18, pp. 4234- 4239 ,(2012) , 10.1158/1078-0432.CCR-11-2010
Aaron J. Schetter, Hirokazu Okayama, Curtis C. Harris, The role of microRNAs in colorectal cancer. Cancer Journal. ,vol. 18, pp. 244- 252 ,(2012) , 10.1097/PPO.0B013E318258B78F
Hanyin Cheng, Lina Zhang, David E Cogdell, Hong Zheng, Aaron J Schetter, Matti Nykter, Curtis C Harris, Kexin Chen, Stanley R Hamilton, Wei Zhang, None, Circulating Plasma MiR-141 Is a Novel Biomarker for Metastatic Colon Cancer and Predicts Poor Prognosis PLoS ONE. ,vol. 6, pp. e17745- ,(2011) , 10.1371/JOURNAL.PONE.0017745
Masanori Hotchi, microRNA expression is able to predict response to chemoradiotherapy in rectal cancer. Molecular and Clinical Oncology. ,vol. 1, pp. 137- 142 ,(2012) , 10.3892/MCO.2012.9
Soly Wang, Zhanjie Liu, Lunshan Wang, Xiaoren Zhang, NF-kappaB signaling pathway, inflammation and colorectal cancer. Cellular & Molecular Immunology. ,vol. 6, pp. 327- 334 ,(2009) , 10.1038/CMI.2009.43
Hajime Shibuya, Hisae Iinuma, Ryu Shimada, Atsushi Horiuchi, Toshiaki Watanabe, Clinicopathological and prognostic value of microRNA-21 and microRNA-155 in colorectal cancer. Oncology. ,vol. 79, pp. 313- 320 ,(2010) , 10.1159/000323283